This event has ended. Visit the official site or create your own event on Sched.
Learn the latest cancer care information to benefit your patients and earn up to 30 CNE contact hours! Register now at congress.ons.org.
Back To Schedule
Friday, April 29 • 6:00pm - 7:30pm
Patient Care in Metastatic CRPC: The Role of XTANDI® (enzalutamide) Capsules

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Please join us for an Astellas Pharma US, Inc. and Medivation, Inc. presentation of XTANDI® in the treatment of metastatic castration-resistant prostate cancer (mCRPC). Haydee Kapin, DNP, ARNP, AOCN, from the University of Miami will walk you through an overview of mCRPC, discuss considerations for the treatment of patients with mCRPC, present patient cases, and review the use of XTANDI and important safety information. We are looking forward to your attendance.

This program is sponsored by Astellas / Medivation

Friday April 29, 2016 6:00pm - 7:30pm CDT
Grand Hyatt, Lonestar Ballroom DEF